急性心肌梗死再灌注治疗研究进展

Research progress of reperfusion therapy for acute myocardial infarction

最近几年,急性心梗(AMI)临床治疗取得了一定效果。其治疗方法也取得了进步,这一点重点体现在上世纪80年代末期之后,临床开展了疾病先期恢复血流,全面促进再灌注治疗,此法取得了满意效果。就再灌注治疗的方式来看,主要包含溶栓治疗(以纤溶酶原激活剂激活血栓中纤溶酶原)、急诊经皮冠状动脉腔内形成术(溶栓失败者首选)其也可被分为:直接性PTCA以及补救性PTCA,冠脉内支架植入术、冠状动脉搭桥术(CABG)、冠状动脉激光形成术(其以内通过激光再通阻塞冠状动脉的新方法)等。结合实际情况,本文全面分析急性心肌梗死再灌注治疗研究进展情况,现将具体结果报告如下。

In recent years,clinical treatment of acute myocardial infarction(AMI)had achieved certain results.Its treatment methods had also made progress,which was mainly reflected in the late 1980 s,when the early recovery of blood flow and the comprehensive promotion of reperfusion therapy were carried out clinically,and satisfactory results were achieved.In terms of the methods of reperfusion therapy,it mainly included thrombolysis,interventional therapy,coronary stenting,coronary artery bypass grafting(GABG)and so on.Combined with the actual situation,this paper comprehensively analyzed the research progress of reperfusion therapy for acute myocardial infarction,and the specific results were reported as follows.